


To provide an income greater than that of the FTSE All Share Index together with capital growth over the longer term.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline | 6.0% | 
| AstraZeneca | 4.4% | 
| BP | 4.3% | 
| Vodafone | 4.3% | 
| Royal Dutch Shell | 4.2% | 
| Imperial Tobacco | 4.0% | 
| Indus Gas | 3.8% | 
| Compass Group | 3.4% | 
| Reed Elsevier | 3.4% | 
| KSK Power Ventur | 3.4% | 
| Key | % Net Assets | 
|---|---|
| 6.0% | |
| 4.4% | |
| 4.3% | |
| 4.3% | |
| 81% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/01/1963 | 
|---|---|
| Fund Manager | n/a | 
| TER | 0.88 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 0.75% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research